相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件:
Powder: -20°C, 3 years; 4°C, 2 years. In solvent: -80°C, 6 months; -20°C, 1 month.
- 库存:
货期:1-2天
- 供应商:
MedChemExpress LLC
- CAS号:
2283355-59-7
- 规格:
10 mM * 1 mL/1 mg/5 mg/10 mg/25 mg
| 规格: | 10 mM * 1 mL | 产品价格: | ¥3300.0 |
|---|---|---|---|
| 规格: | 1 mg | 产品价格: | ¥1363.0 |
| 规格: | 5 mg | 产品价格: | ¥3000.0 |
| 规格: | 10 mg | 产品价格: | ¥4800.0 |
| 规格: | 25 mg | 产品价格: | ¥9500.0 |
MCE 的所有产品仅用作科学研究或药证申报,我们不为任何个人用途提供产品和服务。
MKK7-COV-9
CAS No. : 2283355-59-7
MCE 国际站:MKK7-COV-9
产品活性:MKK7-COV-9 是一种有效的、选择性的 MKK7 共价抑制剂,靶向 MKK7 的一种特异性蛋白-蛋白相互作用。MKK7-COV-9 阻断了原代 B 细胞应对 LPS 的激活的 EC50 值为 4.98 μM.
研究领域:MAPK/ERK Pathway
作用靶点:p38 MAPK
In Vitro: Due to poor permeability, the piperidine analogs MKK7-COV-10 and MKK7-COV-11 proves to be inactive in ICW in 3T3 cells, as well as the carboxylic acid MKK7-COV-8. In contrast, as an amide counterpart , MKK7-COV-9, retains activity (EC50=4.06 μM) and furthermore now provides a new vector for further derivatization.
MKK7-COV-9 (10 μM; 48 hours) shows limited cytotoxic effect only at the highest tested concentration. Only one cell line, HCT116, displayed half-maximal lethal dose (LD50)<10 μM for these two compounds.
MKK7-COV-9 (10 μM; 2 hr pre-incubation) is able to inhibit 60% of the CD86+ response in response to LPS stimulation, in primary mouse B cells , except the negative control MKK7-NEG-1.
JNK is known to mediate activation of B cells in response to lipopolysaccharide (LPS; HY-D1056) through the TLR4 signaling pathway.
MKK7-COV-9 (0-10 μM; 2 hr pre-incubation) is able to mediate activation of B cells in response to LPS through the TLR4 signaling pathway, it shows a dose-response curves for inhibition of LPS induced activation and exhibits an EC50 value of 4.98 μM.(EC50=4.98 μM for MKK7-COV-12; EC50>10 μM for MKK7-COV-7; EC50=2.23 μM for JNK-IN-8).
相关产品:Covalent Screening Library Plus | Bioactive Compound Library Plus | Immunology/Inflammation Compound Library | Kinase Inhibitor Library | MAPK Compound Library | Anti-Cancer Compound Library | Covalent Screening Library | Reprogramming Compound Library | Oxygen Sensing Compound Library | Pyroptosis Compound Library | Anti-Lung Cancer Compound Library | Anti-Cancer Metabolism Compound Library | Neurodegenerative Disease-related Compound Library | Anti-Obesity Compound Library | Angiogenesis-Related Compound Library | Antidepressant Compound Library | Anti-Prostate Cancer Compound Library | Anti-Pulmonary Fibrosis Compound Library | Heterocyclic Compound Library | Pain-Related Compound Library | Membrane Protein-targeted Compound Library | Cysteine Targeted Covalent Library | Highly Selective Inhibitors Library | Serine/Threonine Kinase Inhibitor Library | Adezmapimod | SB 202190 | Afatinib | Doramapimod | Aspirin | Oxidopamine hydrobromide | BI-3406 | Butyzamide | Hesperetin | Muramyl dipeptide | C16-PAF | Ralimetinib dimesylate | PD 169316 | Dehydrocorydaline | LXH254 | Neflamapimod | Diprovocim | Losmapimod | PF-3644022 | Exarafenib | Semapimod tetrahydrochloride | Talmapimod | PH-797804 | Sotorasib racemate | MAPK13-IN-1 | SB 239063 | VX-702
热门产品线:重组蛋白 | 化合物库 | 天然产物 | 荧光染料 | PROTAC | 同位素标记物
Trending products:Recombinant Proteins | Bioactive Screening Libraries | Natural Products | Dye Reagents | PROTAC | Isotope-Labeled Compounds
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验唾液或鼻咽拭子测试对于呼吸道疾病的病原体检测至关重要,未来将越来越多地用于Covid疫苗接种后的免疫检测。在这种情况下,鼻咽拭子或唾液样本的潜在高传染性通常会导致用户危险和相关的监管障碍。然而,对于唾液和鼻咽拭子检测如 SARS-CoV-2 抗原快速检测,安全设计如采用SafetyTector™ S 病毒灭活缓冲液则能很容易即可实现。 CoViD-19大流行突显了良好的诊断方法在控制公众传染病方面的重要性。除了使用核酸扩增检测 (NAT),如现在广为人知的聚合酶链式反应 (PCR)进行早期
Expression, Glycosylation, and Modification of the Spike (S) Glycoprotein of SARS CoV
syndrome (SARS)-coronavirus (CoV) within the host cell, a T7/vaccinia virus-based expression system coupled to immunoprecipitation with anti-S antibodies was used to test and analyze different forms of the S glycoprotein. The state of maturity of the S
PCR 条件对扩增SARS - CoV 多聚酶部分基因的影响
条件非常重要。 关键词:SARS 冠状病毒;套式RT- PCR;检测;条件 详细内容: P.C.R 条件对扩增SARS - CoV 多聚酶部分基因的影响
技术资料暂无技术资料 索取技术资料


















